Pure Global

Total Hip replacement system - India CDSCO Medical Device Registration

Total Hip replacement system is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000088_c0aa1ca53a245f19a42149602a09a398_8d2bf54101301ca4399e7edd0c82e1a0. This device is marketed under the brand name Trident II Acetabular Component System. The license holder is Stryker India Pvt. Ltd.,, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Total Hip replacement system
UID: IMP/MD/2019/000088_c0aa1ca53a245f19a42149602a09a398_8d2bf54101301ca4399e7edd0c82e1a0

Brand Name

Trident II Acetabular Component System

Device Class

Class C

Approving Authority

CDSCO

Product Information

โ€ข Painful disabling joint disease of the hip resulting from degenerative arthritis rheumatoid arthritis posttraumatic arthritis or late stage avascular necrosis. โ€ข Revision of previous unsuccessful femoral head replacement, cup arthroplasty or other procedure. โ€ข Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results. โ€ข Where bone stock is of poor quality or is inadequate for other reconstructive techniques as indicated by deficiencies of the acetabulum When used with MDM Liners โ€ข Treatment of nonunion, femoral neck and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques. โ€ข Dislocation risks When used with Constrained Liners โ€ข The TRIDENT Constrained Acetabular Insert is indicated for use in primary and revision patients at high risk of hip dislocation due to a history of prior dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease, or intraoperative instability. The TRIDENT II Acetabular Shells are indicated for cementless use only

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing